Cancer Vaccine ‘Closer Than We Ever Thought,’ 2025 ... - Curetoday
Feb 20, 2024 · Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said. “We are way closer than we ever thought [we would be] just like three years ago,” said Dr. Patrick Ott, director of the Center for Personal Vaccines, clinical director of the Melanoma Disease Center and director of clinical sciences of the Center for ...
First Patients Dosed in Phase 2 Trial of Ropidoxuridine for …
Oct 29, 2024 · Key Takeaways. Ropidoxuridine is being tested in a phase 2 trial for glioblastoma, aiming to enhance radiation therapy effectiveness. The drug converts to idoxuridine, integrating into DNA to sensitize cells to radiation, with lower toxicity than idoxuridine.
Surrendering to God: How My Faith Led to Healing From Cancer
Aug 8, 2024 · Cancer is a word that strikes fear into the hearts of many. It conjures images of suffering, loss and a battle that often feels unwinnable. For me, cancer wasn’t just a distant concept; it was my reality.
How I Used Turkey Tail Mushrooms Alongside Cancer Treatment
Jan 8, 2024 · At first, I ordered little vials of tincture online. There are plenty of companies that make and sell tincture, a concoction of alcohol imbued or infused with the essence of some plant, herb, or, in this case, mushroom.
FDA Approval of Trodelvy Withdrawn for Urothelial Carcinoma
Oct 22, 2024 · Trodelvy received accelerated approval from the FDA in April 2021 for this specific indication, which was based on findings from the phase 2 TROPHY-U-01 study, which focused on findings related to the tumor response rate and duration of response. The FDA noted that the continued approval of Trodelvy for locally advanced or metastatic urothelial cancer would be contingent on the confirmatory ...
Love Lost: The Effects of Cancer on Marriage and Relationships
Oct 28, 2021 · Impact of a Cancer Diagnosis. Cancer can damage a marriage or relationship in a number of ways, counselors say. “A cancer diagnosis often has a ripple effect on how patients see themselves, on their life and on their relationships,” says Cheyenne Corbett, director of cancer support and survivorship at Duke Cancer Institute in Durham, North Carolina.
Long-Term Study Data Support Keytruda as Standard of Care for …
Oct 1, 2024 · A 10-year follow-up data from the KEYNOTE-006 study showed that Keytruda continued to outperform Yervoy in terms of overall survival, progression-free survival, and melanoma-specific survival for patients with advanced melanoma.
FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow …
Oct 3, 2024 · The Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental biologics license application for Enhertu (trastuzumab deruxtecan) to treat patients with unresectable or metastatic HER2-low or -ultralow breast cancer treated with at least one endocrine therapy in the metastatic setting.
Newer Therapies for Acute Lymphoblastic Leukemia May Reduce …
Nov 19, 2024 · At the 43rd Annual Chemotherapy Foundation Symposium, CURE® spoke with Dr. Hannah Levavi to learn more about these new treatments. Particularly, we discussed how these newer treatments compare with chemotherapy regarding side effects, and how to best optimize treatment plans.
Prostate Cancer Questions Answered, From PSA Levels to …
Oct 29, 2024 · A diagnosis of prostate cancer can be accompanied by plenty of questions for patients, caregivers and loved ones. Here are expert answers to some such questions from the CURE Educated Patient Prostate Cancer Summit chaired by Dr. Kelly L. Stratton of Oklahoma University Health.